{"id":6882,"date":"2023-09-14T19:02:10","date_gmt":"2023-09-14T14:02:10","guid":{"rendered":"https:\/\/www.asiafreepress.com\/?p=6882"},"modified":"2023-09-14T19:02:12","modified_gmt":"2023-09-14T14:02:12","slug":"australian-researchers-make-groundbreaking-test-in-leukemia-treatment","status":"publish","type":"post","link":"https:\/\/www.asiafreepress.com\/en\/news\/australian-researchers-make-groundbreaking-test-in-leukemia-treatment\/","title":{"rendered":"Australian researchers make groundbreaking test in leukemia treatment"},"content":{"rendered":"<p><strong>Australian researchers have developed a groundbreaking test to identify leukemia patients who are candidates for lifelong treatment-free remission (TFR).<\/strong><\/p>\n\n\n\n<p>In a research paper published on Thursday, scientists led by a team from the South Australian Health and Medical Research Institute (SAHMRI) made a major breakthrough in effectively curing chronic myeloid leukemia (CML).<\/p>\n\n\n\n<p>The culmination of six years of research, the test can accurately determine if a patient is suitable to safely stop undergoing treatment for CML.<\/p>\n\n\n\n<p>&#8220;With this discovery, we move the conversation for people with CML from one of lifelong disease control to one of cure,&#8221; Ilaria Pagani, the first author of the research from the SAHMRI and University of Adelaide, said in a media release on Thursday.<\/p>\n\n\n\n<p>&#8220;With the test we have developed, we can predict with a high degree of accuracy who will have an excellent probability of ongoing TFR.&#8221;<\/p>\n\n\n\n<p>According to the U.S.-based Leukemia and Lymphoma Society (LLS), TFR is achieved when a CML patient maintains a deep molecular response (DMR) after undergoing tyrosine kinases inhibitors (TKI) therapy and does not need to restart treatment. CANBERRA, Sept. 14 (Xinhua\/APP) &#8211;:Australian researchers have developed a groundbreaking test to identify leukemia patients who are candidates for lifelong treatment-free remission (TFR).<\/p>\n\n\n\n<p>In a research paper published on Thursday, scientists led by a team from the South Australian Health and Medical Research Institute (SAHMRI) made a major breakthrough in effectively curing chronic myeloid leukemia (CML).<\/p>\n\n\n\n<p>The culmination of six years of research, the test can accurately determine if a patient is suitable to safely stop undergoing treatment for CML.<\/p>\n\n\n\n<p>&#8220;With this discovery, we move the conversation for people with CML from one of lifelong disease control to one of cure,&#8221; Ilaria Pagani, the first author of the research from the SAHMRI and University of Adelaide, said in a media release on Thursday.<\/p>\n\n\n\n<p>&#8220;With the test we have developed, we can predict with a high degree of accuracy who will have an excellent probability of ongoing TFR.&#8221;<\/p>\n\n\n\n<p>According to the U.S.-based Leukemia and Lymphoma Society (LLS), TFR is achieved when a CML patient maintains a deep molecular response (DMR) after undergoing tyrosine kinases inhibitors (TKI) therapy and does not need to restart treatment.<\/p>","protected":false},"excerpt":{"rendered":"<p>Australian researchers have developed a groundbreaking test to identify leukemia patients who are candidates for lifelong treatment-free remission (TFR). In a research paper published on Thursday, scientists led by a team from the South Australian Health and Medical Research Institute (SAHMRI) made a major breakthrough in effectively curing chronic myeloid leukemia (CML). The culmination of [&hellip;]<\/p>","protected":false},"author":28,"featured_media":6883,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[396,2,5,6],"tags":[],"class_list":["post-6882","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest","category-news","category-sciencetech","category-world"],"_links":{"self":[{"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/posts\/6882"}],"collection":[{"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/comments?post=6882"}],"version-history":[{"count":0,"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/posts\/6882\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/media\/6883"}],"wp:attachment":[{"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/media?parent=6882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/categories?post=6882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.asiafreepress.com\/en\/wp-json\/wp\/v2\/tags?post=6882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}